Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Other Non-Current Assets (2022 - 2026)

Genelux (GNLX) posted Other Non-Current Assets of $144000.0 for Q1 2026, little changed on a QoQ basis from $144000.0 in Q4 2025.

Analysis

Genelux (GNLX) Other Non-Current Assets (2022 - 2026) Analysis & Trends

Genelux has reported Other Non-Current Assets for 5 years, with the latest figure at $144000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $144000.0 in Q1 2026; TTM through Mar 2026 was $144000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $144000.0, up 56.52% from the prior year.
  • Other Non-Current Assets was $144000.0 for Q1 2026 at Genelux, roughly flat from $144000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $1.6 million in Q4 2022, with the low at $73000.0 in Q2 2025.
  • Average Other Non-Current Assets over 5 years is $316454.5, with a median of $92000.0 recorded in 2023.
  • The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets sank 94.13% in 2023, then surged 986.96% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $1.6 million in 2022, then tumbled by 94.13% to $92000.0 in 2023, then changed by 0.0% to $92000.0 in 2024, then jumped by 56.52% to $144000.0 in 2025, then changed by 0.0% to $144000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $144000.0 (Q1 2026), $144000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 29.59 Mn
10 Genelux 108.17 Mn 108.17 Mn - 144,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 144,000.00
Dec 31, 2025 144,000.00
Sep 30, 2025 1.00 Mn
Jun 30, 2025 73,000.00
Dec 31, 2024 92,000.00
Sep 30, 2024 92,000.00
Jun 30, 2024 92,000.00
Mar 31, 2024 92,000.00
Dec 31, 2023 92,000.00
Sep 30, 2023 92,000.00
Dec 31, 2022 1.57 Mn